Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and
Preliminary Efficacy of Oral Dosing of CM082 tablets in Chinese Patients With Advanced
Malignant Solid Tumors